A genetic instrument for Mendelian randomization of fibrinogen

European Journal of Epidemiology

Volumn 27, Issue 4, 2012, Pages 267-279

  Ken Dror, Gie ^a   Humphries, Steve E ^a   Kumari, Meena ^b   Kivimaki, Mika ^b   Drenos, Fotios ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Fibrinogen gene; Haplotypes; Mendelian randomization; Tagging SNPs

Indexed keywords

FIBRINOGEN;

ADULT; ALLELE; ARTICLE; FIBRINOGEN ALPHA CHAIN GENE; FIBRINOGEN BETA CHAIN GENE; FIBRINOGEN BLOOD LEVEL; FIBRINOGEN GAMMA CHAIN GENE; GENE; GENE CLUSTER; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HAPLOTYPE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MENDELIAN RANDOMIZATION ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; CORONARY DISEASE; FEMALE; FIBRINOGEN; FOLLOW-UP STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GREAT BRITAIN; HUMANS; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; MULTIGENE FAMILY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84863663919     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-012-9666-x     Document Type: Article

References (57)

1. Danesh J, Lewington S, Thompson SG, et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: An individual participant meta-analysis. JAMA. 2005;294(14):1799-809.
2. Kant JA, Fornace AJ Jr, Saxe D, Simon MI, McBride OW, Crabtree GR. Evolution and organization of the fibrinogen locus on chromosome 4: Gene duplication accompanied by transposition and inversion. Proc Natl Acad Sci USA. 1985;82(8):2344-8.
3. Friedlander Y, Elkana Y, Sinnreich R, Kark JD. Genetic and environmental sources of fibrinogen variability in Israeli families: The Kibbutzim Family Study. Am J Hum Genet. 1995;56(5): 1194-206.
4. Humphries SE, Cook M, Dubowitz M, Stirling Y, Meade TW. Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations. Lancet. 1987;1(8548):1452-5.
5. de Maat MP, Kastelein JJ, Jukema JW, et al. 455G/A polymorphism of the beta-fibrinogen gene is associated with the progression of coronary atherosclerosis in symptomatic men: Proposed role for an acute-phase reaction pattern of fibrinogen. REGRESS group. Arterioscler Thromb Vasc Biol. 1998;18(2): 265-71.
6. Simmonds RE, Hermida J, Rezende SM, Lane DA. Haemostatic genetic risk factors in arterial thrombosis. Thromb Haemost. 2001;86(1):374-85.
7. Voetsch B, Loscalzo J. Genetic determinants of arterial thrombosis. Arterioscler Thromb Vasc Biol. 2004;24(2):216-29.
8. Keavney B, Danesh J, Parish S, et al. Fibrinogen and coronary heart disease: Test of causality by 'Mendelian randomization'. Int J Epidemiol. 2006;35(4):935-43.
9. Davey Smith G, Harbord R, Ebrahim S. Fibrinogen, C-reactive protein and coronary heart disease: Does Mendelian randomization suggest the associations are non-causal? QJM. 2004;97(3):163-6.
10. Bound J, Jaeger D, Baker R. Problems with instrumental variables estimation when the correlation between the instruments and the endogenous explanatory variable is weak. J Am Stat Assoc. 1995;90(430):443-50.
11. Staiger D, Stock J. Instrumental variables regression with weak instruments. Econometrica. 1997;65(3):557-86.
12. Meade TW, Humphries SE, De Stavola BL. Commentary: Fibrinogen and coronary heart disease-Test of causality by 'Mendelian' randomization by Keavney et al. Int J Epidemiol. 2006;35(4):944-7.
13. Mannila MN, Eriksson P, Lundman P, et al. Contribution of haplotypes across the fibrinogen gene cluster to variation in risk of myocardial infarction. Thromb Haemost. 2005;93(3):570-7.
14. Uitte de Willige S, de Visser MC, Houwing-Duistermaat JJ, Rosendaal FR, Vos HL, Bertina RM. Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels. Blood. 2005;106(13):4176-83.
15. Cooper JA, Miller GJ, Bauer KA, et al. Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease. Circulation. 2000;102(23):2816-22.
16. Miller GJ, Bauer KA, Barzegar S, et al. The effects of quality and timing of venepuncture on markers of blood coagulation in healthy middle-aged men. Thromb Haemost. 1995;73(1):82-6.
17. Miller GJ, Bauer KA, Barzegar S, Cooper JA, Rosenberg RD. Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease. Thromb Haemost. 1996;75(5): 767-71.
18. Clauss A. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol. 1957;17(4):237-46.
19. World Health Organization. Regional Office for Europe. Myocardial infarction community registers: Results of a WHO international collaborative study coordinated by the Regional Office for Europe. Copenhagen: Regional Office for Europe, World Health Organization; 1976.
20. Prineas RJ, Crow RS, Blackburn H. The Minnesota code manual of electrocardiographic findings: Standards and procedures for measurement and classification. Boston, MA; Bristol: John- Wright; 1982.
21. Drenos F, Talmud PJ, Casas JP, et al. Integrated associations of genotypes with multiple blood biomarkers linked to coronary heart disease risk. Hum Mol Genet. 2009;18(12):2305-16.
22. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat Genet. 2005;37(11):1217-23.
23. Thomas A, Lamlum H, Humphries S, Green F. Linkage disequilibrium across the fibrinogen locus as shown by five genetic polymorphisms, G/A-455 (HaeIII), C/T-148 (HindIII/AluI), T/G ? 1689 (AvaII), and BclI (beta-fibrinogen) and TaqI (alphafibrinogen), and their detection by PCR. Hum Mutat. 1994;3(1): 79-81.
24. Baumann RE, Henschen AH. Linkage disequilibrium relationships among four polymorphisms within the human fibrinogen gene cluster. Hum Genet. 1994;94(2):165-70.
25. Marmot M, Brunner E. Cohort profile: The whitehall II study. Int J Epidemiol. 2005;34(2):251-6.
26. Talmud PJ, Drenos F, Shah S, et al. Gene-centric association signals for lipids and apolipoproteins identified via the Human- CVD BeadChip. Am J Hum Genet. 2009;85(5):628-42.
27. Steptoe A, Kunz-Ebrecht SR, Owen N. Lack of association between depressive symptoms and markers of immune and vascular inflammation in middle-aged men and women. Psychol Med. 2003;33(4):667-74.
28. Keating BJ, Tischfield S, Murray SS, et al. Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies. PLoS ONE. 2008;3(10):e3583.
29. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001;68(4):978-89.
30. Stephens M, Scheet P. Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am J Hum Genet. 2005;76(3):449-62.
31. Graham RR, Langefeld CD, Gaffney PM, et al. Genetic linkage and transmission disequilibrium of marker haplotypes at chromosome 1q41 in human systemic lupus erythematosus. Arthritis Res. 2001;3(5):299-305.
32. Marchini J, Cutler D, Patterson N, et al. A comparison of phasing algorithms for trios and unrelated individuals. Am J Hum Genet. 2006;78(3):437-50.
33. Stephens M, Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet. 2003;73(5):1162-9.
34. Wood AM, White IR, Thompson SG, et al. Correcting for multivariate measurement error by regression calibration in meta-analyses of epidemiological studies. Stat Med. 2009;28(7):1067-92.
35. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335(8692):765-74.
36. Balding DJ. A tutorial on statistical methods for population association studies. Nat Rev Genet. 2006;7(10):781-91.
37. Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G. Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27(8): 1133-63.
38. Clarke P, Windmeijer F. Instrumental variable estimators for binary outcomes: Working paper No. 09/209. Bristol: The Centre for Market & Public Organisations; 2009.
39. Lawlor DA, Harbord RM, Tybjaerg-Hansen A et al. Using genetic loci to understand the relationship between adiposity and psychological distress: A Mendelian Randomization study in the Copenhagen General Population Study of 53,221 adults. J Intern Med. 2011;269:525-37.
40. Smith AJ, Palmen J, Putt W, Talmud PJ, Humphries SE, Drenos F. Application of statistical and functional methodologies for the investigation of genetic determinants of coronary heart disease biomarkers: Lipoprotein lipase genotype and plasma triglycerides as an exemplar. Hum Mol Genet. 2010;19(20):3936-47.
41. Martens EP, Pestman WR, de Boer A, Belitser SV, Klungel OH. Instrumental variables: Application and limitations. Epidemiology. 2006;17(3):260-7.
42. Cardon LR, Bell JI. Association study designs for complex diseases. Nat Rev Genet. 2001;2(2):91-9.
43. Colhoun HM, McKeigue PM, Davey Smith G, et al. Problems of reporting genetic associations with complex outcomes. Lancet. 2003;361(9360):865-72.
44. Clayton D, McKeigue PM. Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet. 2001;358(9290):1356-60.
45. Zeggini E, Rayner W, Morris AP, et al. An evaluation of HapMap sample size and tagging SNP performance in large-scale empirical and simulated data sets. Nat Genet. 2005;37(12):1320-2.
46. Cambon-Thomsen A. Assessing the impact of biobanks. Nat Genet. 2003;34(1):25-6.
47. Baumann RE, Henschen AH. Human fibrinogen polymorphic site analysis by restriction endonuclease digestion and allele-specific polymerase chain reaction amplification: Identification of polymorphisms at positions A alpha 312 and B beta 448. Blood. 1993;82(7):2117-24.
48. Reiner AP, Carty CL, Carlson CS, et al. Association between patterns of nucleotide variation across the three fibrinogen genes and plasma fibrinogen levels: The Coronary Artery Risk Development in Young Adults (CARDIA) study. J Thromb Haemost. 2006;4(6):1279-87.
49. Koch W, Hoppmann P, Biele J, Mueller JC, Schomig A, Kastrati A. Fibrinogen genes and myocardial infarction: A haplotype analysis. Arterioscler Thromb Vasc Biol. 2008;28(4):758-63.
50. Carty CL, Cushman M, Jones D, et al. Associations between common fibrinogen gene polymorphisms and cardiovascular disease in older adults. The Cardiovascular Health Study. Thromb Haemost. 2008;99(2):388-95.
51. Friedlander Y, Kark JD, Sinnreich R, Basso F, Humphries SE. Combined segregation and linkage analysis of fibrinogen variability in Israeli families: Evidence for two quantitative-Trait loci, one of which is linked to a functional variant (-58G[A) in the promoter of the alpha-fibrinogen gene. Ann Hum Genet. 2003;67(Pt 3):228-41.
52. van't Hooft FM, von Bahr SJ, Silveira A, Iliadou A, Eriksson P, Hamsten A. Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration. Arterioscler Thromb Vasc Biol. 1999;19(12):3063-70.
53. Behague I, Poirier O, Nicaud V, et al. Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du Myocarde. Circulation. 1996;93(3):440-9.
54. Mannila MN, Eriksson P, Ericsson CG, Hamsten A, Silveira A. Epistatic and pleiotropic effects of polymorphisms in the fibrinogen and coagulation factor XIII genes on plasma fibrinogen concentration, fibrin gel structure and risk of myocardial infarction. Thromb Haemost. 2006;95(3):420-7.
55. Mannila MN, Eriksson P, Leander K, et al. The association between fibrinogen haplotypes and myocardial infarction in men is partly mediated through pleiotropic effects on the serum IL-6 concentration. J Intern Med. 2007;261(2):138-47.
56. Kardys I, Uitterlinden AG, Hofman A, Witteman JC, de Maat MP. Fibrinogen gene haplotypes in relation to risk of coronary events and coronary and extracoronary atherosclerosis: The Rotterdam Study. Thromb Haemost. 2007;97(2):288-95.
57. Theodoraki EV, Nikopensius T, Suhorutsenko J, et al. Fibrinogen beta variants confer protection against coronary artery disease in a Greek case-control study. BMC Med Genet. 2010;11:28.